|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
DE69912441T2
(de)
|
1998-08-19 |
2004-08-19 |
Skyepharma Canada Inc., Verdun |
Injizierbare wässerige propofoldispersionen
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
WO2003080027A1
(en)
*
|
2002-03-20 |
2003-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
AU2003286725B2
(en)
*
|
2002-10-29 |
2007-07-12 |
Transform Pharmaceuticals, Inc. |
Propofol with cysteine
|
|
CA2509365C
(en)
|
2002-12-09 |
2012-08-07 |
American Bioscience, Inc. |
Compositions and methods of delivery of pharmacological agents
|
|
US7468394B1
(en)
*
|
2003-03-11 |
2008-12-23 |
Amphastar Pharmaceuticals, Inc. |
Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation
|
|
US20040225022A1
(en)
*
|
2003-05-09 |
2004-11-11 |
Desai Neil P. |
Propofol formulation containing reduced oil and surfactants
|
|
US8476010B2
(en)
*
|
2003-07-10 |
2013-07-02 |
App Pharmaceuticals Llc |
Propofol formulations with non-reactive container closures
|
|
US8546453B2
(en)
*
|
2003-08-14 |
2013-10-01 |
Rensheng Zhang |
Propofol compositions and methods for reducing pain associated with propofol injection
|
|
RU2290169C1
(ru)
*
|
2005-06-23 |
2006-12-27 |
Открытое Акционерное Общество "Фаберлик" |
Косметическое и/или дерматологическое средство и антиоксидант
|
|
LT3311805T
(lt)
*
|
2005-08-31 |
2020-04-27 |
Abraxis Bioscience, Llc |
Kompozicijos, apimančios silpnai vandenyje tirpius farmacinius agentus ir priešmikrobinius agentus
|
|
EP3527202A1
(en)
*
|
2005-08-31 |
2019-08-21 |
Abraxis BioScience, LLC |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
|
CN101411685B
(zh)
*
|
2007-10-19 |
2011-04-20 |
上海医药工业研究院 |
一种静脉麻醉药2,6-二异丙基苯酚微乳组合物及其制备方法
|
|
PL2547323T3
(pl)
|
2010-03-17 |
2016-07-29 |
Novaliq Gmbh |
Kompozycja farmaceutyczna do leczenia podwyższonego ciśnienia wewnątrzgałkowego
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
ES2711760T3
(es)
*
|
2011-01-04 |
2019-05-07 |
Novaliq Gmbh |
Emulsiones de aceite/agua que comprenden alcanos semifluorados
|
|
CN103501775A
(zh)
*
|
2011-03-04 |
2014-01-08 |
格吕伦塔尔有限公司 |
他喷他多的胃肠外给药
|
|
MX388963B
(es)
|
2011-03-04 |
2025-03-20 |
Gruenenthal Gmbh |
Formulacion farmaceutica acuosa de tapentadol para administracion oral
|
|
JP2019142972A
(ja)
*
|
2011-03-04 |
2019-08-29 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
タペンタドールの非経口的投与
|
|
ES2910085T3
(es)
|
2011-03-04 |
2022-05-11 |
Gruenenthal Gmbh |
Composición farmacéutica acuosa semisólida que contiene tapentadol
|
|
DK2714010T3
(en)
|
2011-05-25 |
2017-06-12 |
Novaliq Gmbh |
TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORED ALKANES
|
|
JP2013001700A
(ja)
*
|
2011-06-21 |
2013-01-07 |
Fujifilm Corp |
プロポフォール含有水中油型エマルション組成物
|
|
JP5759804B2
(ja)
*
|
2011-06-27 |
2015-08-05 |
富士フイルム株式会社 |
容器詰製剤
|
|
KR101989648B1
(ko)
|
2012-01-23 |
2019-06-14 |
노바리크 게엠베하 |
부분불소화 알칸에 기초한 안정화된 단백질 조성물
|
|
WO2013172999A1
(en)
|
2012-05-16 |
2013-11-21 |
Mewa Singh |
Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
|
|
CN113679699B
(zh)
|
2012-09-12 |
2022-10-28 |
诺瓦利克有限责任公司 |
包含半氟化烷烃的混合物的组合物
|
|
AU2013314303B2
(en)
|
2012-09-12 |
2018-01-18 |
Novaliq Gmbh |
Semifluorinated alkane compositions
|
|
PT3024484T
(pt)
|
2013-07-23 |
2018-10-24 |
Novaliq Gmbh |
Composições de anticorpo estabilizadas
|
|
PE20171651A1
(es)
|
2015-03-27 |
2017-11-13 |
Gruenenthal Chemie |
Formulacion estable para administracion parenteral de tapentadol
|
|
US10821087B2
(en)
*
|
2015-07-24 |
2020-11-03 |
Neon Laboratories Limited |
Stabilized injectable emulsion of Propofol and Ketamine
|
|
WO2017031261A1
(en)
|
2015-08-20 |
2017-02-23 |
Mewa Singh |
Polyphenolic polymer to make water-insoluble molecules become water-soluble
|
|
US11154513B2
(en)
|
2015-09-30 |
2021-10-26 |
Novaliq Gmbh |
Semifluorinated compounds
|
|
CN110403923B
(zh)
|
2015-09-30 |
2021-09-21 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
|
PT3442480T
(pt)
|
2016-06-23 |
2019-12-23 |
Novaliq Gmbh |
Método de administração tópica
|
|
CA3036297C
(en)
|
2016-09-22 |
2023-09-05 |
Novaliq Gmbh |
Pharmaceutical compositions for use in the therapy of blepharitis
|
|
WO2018055101A1
(en)
|
2016-09-23 |
2018-03-29 |
Novaliq Gmbh |
Ophthalmic compositions comprising ciclosporin
|
|
EP3515412B1
(en)
|
2016-09-23 |
2025-04-23 |
Grünenthal GmbH |
Stable formulation for parenteral administration of tapentadol
|
|
EP4374851B1
(en)
|
2016-12-23 |
2026-04-15 |
Novaliq GmbH |
Ophthalmic composition for treatment of dry eye disease
|
|
CA3058097C
(en)
|
2017-04-21 |
2024-01-02 |
Novaliq Gmbh |
Iodine compositions
|
|
US11278503B2
(en)
|
2017-05-12 |
2022-03-22 |
Novaliq Gmbh |
Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
|
|
MX2020003534A
(es)
|
2017-09-27 |
2020-07-29 |
Novaliq Gmbh |
Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
|
|
WO2019068763A1
(en)
|
2017-10-04 |
2019-04-11 |
Novaliq Gmbh |
OPHTHALMIC COMPOSITIONS COMPRISING F6H8
|
|
KR20200128407A
(ko)
|
2018-03-02 |
2020-11-12 |
노바리크 게엠베하 |
네비볼롤을 포함하는 약제학적 조성물
|
|
SG11202007860XA
(en)
|
2018-03-28 |
2020-09-29 |
Novaliq Gmbh |
Pharmaceutical composition comprising timolol
|
|
CN112153970A
(zh)
|
2018-04-27 |
2020-12-29 |
诺瓦利克有限责任公司 |
用于治疗青光眼的包含他氟前列素的眼用组合物
|
|
SG11202102820VA
(en)
|
2018-10-12 |
2021-04-29 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
|
EP3923907B1
(en)
|
2019-02-13 |
2024-09-25 |
Novaliq GmbH |
Compositions and methods for the treatment of ocular neovascularization
|